"Beijing Sun-Novo Pharmaceutical Research Co., Ltd."Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual Report

About this update from Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A

Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual ReportThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference:View Attachment

View stock analysis, news, and events for Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A